4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
Molecular Partners AG (NASDAQ:MOLN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...
New S32K5 microcontroller family advances zonal SDV architectures and extends the NXP CoreRide platform
New family of MCUs helps automakers shift to SDVs with a range of zonal and electrification architecturesCombines leading-edge core performance ...
4D Molecular Therapeutics, Inc.: 4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
MarketWatch19h
E-Mini Nasdaq 100 Index Continuous Contract
2-Year U.S. Treasury Note Continuous Contract $103.551 0.086 0.08% 5-Year U.S. Treasury Note Continuous Contract $107.930 0.203 0.19% 10-Year U.S. Treasury Note Continuous Contract $110.922 0.281 ...
Kratos Awarded Potential $50 Million Short/Medium Range Sub-Orbital Vehicle II Contract to Support Missile Defense Related Missions
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security, and global markets, today announced the award of the Short/Medium Range Sub-Orbital ...
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
NVIDIA and Microsoft Open Next Era of Gaming With Groundbreaking Neural Shading Technology
NVIDIA has partnered with Microsoft to bring neural shading support to the Microsoft DirectX preview in April, giving developers access to AI Tensor Cores in NVIDIA GeForce RTX™ GPUs to accelerate ...
Business Insider6d
EpicQuest Education discloses Nasdaq listing deficiency notice
EpicQuest Education (EEIQ)announced that it received a delinquency notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC on March 5, 2025 indicating that ...
Business Insider6d
Rail Vision receives Nasdaq notice of non-compliance
Rail Vision (RVSN) announced that on March 6, the company received a written notice from the Nasdaq Stock Market indicating that the company was not in compliance with Nasdaq Listing Rule 5550(a ...
Business Insider6d
Lottery.com regains full compliance with Nasdaq listing rules
Lottery.com (LTRY) received a notice from The Nasdaq Stock Market determining that as a result of the closing bid price of the Company’s common share being $1.00 or above for the last twenty ...
Business Insider6d
Vaccinex to delist common stock from Nasdaq
Vaccine announced that it has notified Nasdaq of its decision to delist the company’s shares of common stock, par value $0.0001 per share, from Nasdaq. Trading in the Common Stock on Nasdaq has ...